Page last updated: 2024-09-03

sr 48692 and fluphenazine depot

sr 48692 has been researched along with fluphenazine depot in 1 studies

Compound Research Comparison

Studies (sr 48692)	Trials (sr 48692)	Recent Studies (post-2010) (sr 48692)	Studies (fluphenazine depot)	Trials (fluphenazine depot)	Recent Studies (post-2010) (fluphenazine depot)
203	3	36	326	78	12

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
McCormick, SE; Stoessl, AJ	1

Other Studies

1 other study(ies) available for sr 48692 and fluphenazine depot

Article	Year
Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia. Neuroscience, 2003, Volume: 119, Issue:2 Topics: Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Globus Pallidus; Male; Mastication; Prodrugs; Pyrazoles; Quinolines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Stereotyped Behavior; Substantia Nigra	2003

Article

Year

Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.

Neuroscience, 2003, Volume: 119, Issue:2

Topics: Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Globus Pallidus; Male; Mastication; Prodrugs; Pyrazoles; Quinolines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Stereotyped Behavior; Substantia Nigra

2003